Ticker	Volume	Price	Price Delta
DJIA	12,580.70	+125.86	1.01%
S&P 500	1,332.42	+14.60	1.11%
Nasdaq	2,870.99	+33.46	1.18%

Ticker	Volume	Price	Price Delta
STOXX 50	2,160.31	+12.39	0.58%
FTSE 100	5,391.14	+34.80	0.65%
DAX	6,396.84	+73.65	1.16%

Ticker	Volume	Price	Price Delta
Nikkei	8,571.90	-85.18	-0.98%
TOPIX	718.22	-8.81	-1.21%
Hang Seng	18,646.80	-408.70	-2.14%

Gold

1,548.20

-0.18%

EUR-USD

1.2465

-0.3033%

Nasdaq

2,870.99

+1.18%

DJIA

12,580.70

+1.01%

S&P 500

1,332.42

+1.11%

FTSE 100

5,391.14

+0.65%

STOXX 50

2,160.31

+0.58%

DAX

6,396.84

+1.16%

Oil (WTI)

90.31

-0.50%

U.S. 10-year

1.719%

-0.019

BAC:US

7.44

+4.06%

FB:US

28.84

-9.62%

Bloomberg

Exchange: -
Sector: Consumer, Non-cyclical
Industry: Biotechnology
Sub-Industry: Medical-Biomedical/Gene

Genzyme Corp

GENZ:US

Acquired

Genzyme Corp (GENZ:US) was acquired by SAN:FP

Company Profile

Genzyme Corporation provides biotechnology products development. The Company focuses on developing therapeutics for rare disorders, renal diseases, orthopaedics, cancer, transplant and immune disease, and diagnostic and predictive testing. Genzyme serves healthcare provider throughout worldwide.